Immunology and Immunotoxicity

Pharmaron’s preclinical immunology team supports immunotoxicity evaluations and preclinical development of biopharmaceuticals. Our technology platforms include, immunochemistry, immunohistochemistry, flow cytometry, HELISA, qPCR and next generation sequencing. Study designs follow regulatory guidelines to support submission to multiple regulatory agencies. Test articles include antibody, recombinant protein, peptide, ADC, antisense oligonucleotide, siRNA, vaccine and reengineered cells.

• Biopharmaceutical dose formulation analysis
• Biopharmaceutical PK and TK: LBA-based, HELISA-based, qPCR-based, etc.
• Immunogenicity
• Immunophenotyping
• T-cell Dependent Antibody Response (TDAR)
• Tissue Cross Reactivity (TCR)
• Biomarker analysis